← FDA DRUG APPROVALS
FDA ANDA · ANDA219060
FLUTICASONE PROPIONATE
fluticasone propionate nasal
Sponsor: RUBICON RESEARCH
APPLICATION
ANDA219060
TYPE
ANDA
ORIGINAL APPROVAL
2025-08-15
LATEST ACTION
2025-08-15
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Over-the-counter
Products
FLUTICASONE PROPIONATEOver-the-counter
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2025-08-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.